Bridge Therapeutics
Pre-clinicalBridge Therapeutics are pursuing FDA approval of a patented drug combination for the treatment of chronic pain in opioid experienced patients.
Founded
2019
Focus
Small Molecules
About
Bridge Therapeutics are pursuing FDA approval of a patented drug combination for the treatment of chronic pain in opioid experienced patients.
Funding History
1Total raised: $12M
Series A$12MUndisclosedNov 15, 2021
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile